food and drug administration fda

FDA bans red dye No. 3

FDA Bans Red Dye No. 3 From Food, Beverages and Ingested Drugs, Citing Link to Cancer in Lab Rats

After decades of debate, the Food and Drug Administration (FDA) has announced a ban on Red Dye No. 3, a synthetic food coloring that’s been linked to cancer in male lab rats. The decision comes after a petition filed in 2022 by advocacy groups,

Forbes · 1d

FDA Bans Red Dye 3 On Cusp Of Potentially Big Changes In Food Industry

FDA’s ban on Red 3 is a shot across the bow to the food sector that could ironically help facilitate Kennedy’s pursuit of further changes.

Austin American-Statesman · 2d

FDA announces ban on Red No. 3 food dye. Which of your favorite food items contain it

The Food and Drug Administration said it is banning the use of Red No. 3, which is founds in over 3,000 products. Here's a list of a few items

4don MSN

Food shoppers could see nutrition facts on the front, as FDA unveils proposed packaging rules

The Food and Drug Administration released on Tuesday its long-awaited proposal to require food manufacturers to put some ...

3don MSN

New FDA proposal would put 'front-of-package' nutrition labels on food products

The U.S. Food and Drug Administration hopes "front-of-package" labeling will better improve the American population's health, ...

AstraZeneca’s Datroway approved in U.S. for HER2-negative breast cancer patients

DXd, has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor HR-positive, HER2-negative breast cancer who have received prior endocrine-based ...

2don MSN

FDA authorizes Zyn nicotine pouches, cites lower risk than cigarettes

The FDA authorized the marketing of 20 Zyn products on Thursday, marking the first allowance for the fast-growing nicotine ...

For first time, FDA approves marketing of nicotine pouch products

The U.S. Food and Drug Administration on Thursday okayed the marketing of 20 Zyn nicotine pouch products after undertaking an ...

1don MSN

FDA approves new MCL treatment by AstraZeneca

WILMINGTON, Del. - The U.S. Food and Drug Administration (FDA) has granted approval to AstraZeneca (NASDAQ:AZN)'s CALQUENCE® ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results